Page 204 - 80 guidelines for the treatment of malaria_opt

nd
Guidelines for the treatment of malaria – 2 edition

diarrhoea 34, 74, 76, 88, 90, 91, 93, 98
dichloroacetate 45
dihydroartemisinin 3, 14, 16, 17, 19, 21, 31, 32, 39, 41, 42, 57, 65, 80, 82–84, 102, 134, 145, 162, 172
plus piperaquine 16, 21
doxycycline 18, 19, 21, 31, 32, 34, 39, 41, 93–95, 102, 169
drug resistance 1, 2, 8, 17, 22, 56, 71, 72, 113, 114, 115, 120, 122, 123, 124, 125, 126, 127, 128, 130, 131, 172

E
education 23, 24, 56, 60, 127, 170
efavirenz 25, 33
elimination (pre-) 6, 8, 58, 73, 75, 76, 79, 81, 82, 83, 86, 87, 89, 91, 93, 98, 99, 100, 101, 102, 113, 125, 127,
128, 129
emergence of resistance 13, 30, 49, 124, 125, 128–130

F

FDCs (fixed-dose combinations) 17–22, 76, 77
first-line treatment 16, 18, 26, 30, 32, 52, 131
G

G6PD deficiency 12, 28, 51, 52, 58, 77, 87, 170–172, 180
gametocyte(s) 7, 14, 15, 58, 80, 89, 90, 109–114, 125, 126, 128, 134, 136–143, 146, 147, 148, 150, 151
GRADE 2–4, 14–16, 38, 50, 51, 63–67, 70, 134–136, 138, 140, 142, 144–146, 148, 150, 154–156, 173, 174, 176,
178, 179
H

haemodialysis 43, 44
haemofiltration 43, 44
halofantrine 31, 92
heparin 45
hepatotoxicity 25, 78, 80, 93
high-transmission settings see transmission
HIV 1, 10, 12, 32, 33, 117, 128
home-based management (HMM) 24
hyperimmune 45
hyperparasitaemic 22, 124
hypnozoites 48–50, 53, 166, 167, 169, 171
hypoalbuminaemia 34
hypoglycaemia 5, 27, 35, 38, 43, 44, 47, 77, 91, 154, 156–158, 161
I

infants 28–30, 32, 55, 59, 94, 97, 98, 166
infection
acquired 7, 127
bacterial 46, 47, 93, 96

190